HFA Scientific Documents and Publications
European Journal of Heart Failure
Advancing knowledge in the field of heart failure management.
The journal publishes reviews and editorials to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as the clinical, social and population sciences all form part of the discipline that is heart failure.
ESC Heart Failure
ESC Heart Failure is the open access journal of the HFA dedicated to the advancement of knowledge in the field of heart failure.
The journal improves the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as the clinical, social and population sciences all form part of the discipline that is heart failure.
Publications
Scientific Statements
Our scientific statements interpret scientific evidence and give you our summary position on the topic without offering specific advice
Recommended Reading
Topical articles suggested by the HFA
Download the annual HFA Compendium of position papers and consensus documents
Exclusive access for HFA Members and Fellows of the HFA
- Become a Member and download it for FREE
- If you are a Member, log in to access the Compendium
Not a member yet?
Joining the Heart Failure Association (HFA) offers numerous benefits for healthcare professionals specialising in heart failure.
You can enjoy:
ESC Clinical Practice Guidelines with a Focus on Heart Failure
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Since the publication of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, there have been several randomised controlled trials that should change patient management ahead of the next scheduled full guideline.
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
The aim of this ESC guideline is to help health professionals manage people with heart failure (HF) according to the best available evidence. Fortunately, we now have a wealth of clinical trials to help us select the best management to improve the outcomes for people with HF; for many, it is now both preventable and treatable.
2025 ESC Guidelines for the management of myocarditis and pericarditis
These guidelines introduce a comprehensive, patient-oriented framework for the diagnosis and management of IMPS, spanning the full disease spectrum.
2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease
This clinical consensus statement on mental health and cardiovascular disease highlights the multidirectional relationship between mental health, cardiovascular health and cardiovascular disease and its impact on cardiovascular risk and prognosis.
2025 ESC Guidelines for the management of cardiovascular disease and pregnancy
The current Guidelines for the management of cardiovascular disease and pregnancy support health care professionals to manage and care for women with cardiovascular diseases before, during and after pregnancy.
2024 ESC Guidelines for the management of atrial fibrillation
In this iteration of the European Society of Cardiology (ESC) Clinical Practice Guidelines on Atrial Fibrillation, the task force has consolidated and evolved past approaches to develop the AF-CARE framework.
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
The current Guidelines on cardiovascular disease and diabetes are designed to guide prevention and management of the manifestations of CVD in patients with diabetes.
2023 ESC Guidelines for the management of cardiomyopathies
The objective of this guideline is to help healthcare professionals diagnose and manage patients with cardiomyopathies of all ages according to the best available evidence and to provide a practical diagnostic and treatment framework for patients and their relatives.
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Pulmonary hypertension (PH) is a pathophysiological disorder, which may involve multiple clinical conditions and may be associated with a variety of cardiovascular and respiratory diseases.
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
The 2021 ESC Guidelines redefine cardiac pacing – covering CRT, His and left bundle branch pacing, advanced diagnostics, risk reduction, remote monitoring, and shared decision-making for better patient care.
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease Guidelines
Endomyocardial biopsy remains a debated tool in cardiovascular care. The latest guidelines clarify when EMB adds diagnostic, prognostic, and therapeutic value—balancing benefits against procedural risks.
More to Explore
Cardiovascular Research
Cardiovascular Research (CVR) is the international journal of the European Society of Cardiology that deals with basic and translational research across different disciplines and areas.
CardioScape
CardioScape outlines the current CVD research and innovation landscape across Europe.
Stay up to date
Great science, direct to your inbox!
Sign up for free to the HFA bulletin.